Benchling closes at $14.5M in Series B round

BioTech |  News | 0 Comment | 15 Jun, 2018

Life Sciences informatics company Benchling said that it closed a $14.5 million Series B round of venture capital. Benchmark led the round, with participation from Fidelity Investments' F-P...Read more

2018 BIO International Convention makes history

BioTech |  News | 0 Comment | 15 Jun, 2018

The 2018 BIO International Convention (BIO 2018) recently wrapped up four days of programming under the theme of “Make History.” Hosted by the Biotechnology Innov...Read more

Israeli biotech startups to get new workspace

BioTech |  News | 0 Comment | 14 Jun, 2018

LR Group is investing NIS 50 million in building and operating three shared workspaces for biotechnology and medical startups near three hospitals in Israel - Hadassah Medical Centre Ein Ke...Read more

HIV vaccine developed by NIH found active in animals

BioTech |  News | 0 Comment | 13 Jun, 2018

Over the past several years, HIV researchers have identified many broadly neutralizing antibodies that can protect human cells in the lab. Scientists examine the sites, or epitopes, on...Read more

Vergent Bioscience raises $8.7M in Series A financing round

BioTech |  News | 0 Comment | 13 Jun, 2018

Vergent Bioscience, a cancer-focused biotechnology company has announced that it raised $8.7 million in a Series A financing round led by Spring Mountain Capital to fund its preclinical and...Read more

FTC investigates DNA testing firms over privacy

BioTech |  News | 0 Comment | 12 Jun, 2018

DNA testing companies like 23andMe and Ancestry.com are being investigated by the Federal Trade Commission over their policies for handling personal info and genetic data and how they share...Read more

Juvenescence raises $50 M in Series A financing

BioTech |  News | 0 Comment | 12 Jun, 2018

Juvenescence Limited, a leader in the development of therapies to slow, halt or potentially reverse aging, has successfully raised $50 million in its Series A financing. The Series A financ...Read more

Fluence Analytics announces partnership with Nihon Rufuto

BioTech |  News | 0 Comment | 08 Jun, 2018

Fluence Analytics, a manufacturer of industrial and laboratory analytics products has announced that it has signed a distribution agreement with Nihon Rufuto, a Japanese company specializin...Read more

BMGF comes up with nonprofit biotech company in Boston

BioTech |  News | 0 Comment | 08 Jun, 2018

Over the past year or so, the Bill and Melinda Gates Foundation has built what is essentially a nonprofit biotechnology company in Boston, with a $100 million budget and a staff targeted to...Read more

Macrogen establishes a subsidiary in Singapore

BioTech |  News | 0 Comment | 07 Jun, 2018

Macrogen, Inc., a precision medicine biotechnology company, announced that it has established Macrogen Asia Pacific Pte. Ltd., a subsidiary in Singapore in March and is hard at work on fi...Read more

Pfizer to expand venture with $600 M investment

BioTech |  News | 0 Comment | 06 Jun, 2018

Pfizer Inc. has announced that it plans to invest $600 million in biotechnology and other emerging growth companies through Pfizer Ventures, the company’s venture investment vehicle.&...Read more

Wize Pharma signs distribution agreement in China for LO2A

BioTech |  News | 0 Comment | 06 Jun, 2018

Singapore-  Wize Pharma, a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, announced that it has signed an exclusive distribution agreement w...Read more

SGInnovate delves deep into tech at ARISE

BioTech |  News | 0 Comment | 05 Jun, 2018

Singapore- SGInnovate is presenting ARISE, Southeast Asia’s preeminent deep tech event at innovfest unbound 2018. ARISE 2018 will provide a platform for researchers, en...Read more

USFDA approves Mylan and Biocon’s Fulphila

BioTech |  News | 0 Comment | 05 Jun, 2018

Mylan N.V.  and Biocon Ltd. have announced that the U.S. Food and Drug Administration (FDA) has approved Mylan’s Fulphila (pegfilgrastim-jmbd), a biosimilar to Neu...Read more

Neon Therapeutics is planning to raise $115 M

BioTech |  News | 0 Comment | 04 Jun, 2018

Neon Therapeutics, which is developing an anti-cancer vaccine, is planning on raising $115 million in a Nasdaq IPO at a company value of $450 million, before money. Neon Therapeutics is a ...Read more

Spin-outs from University of Queensland generate $600 million

BioTech |  News | 0 Comment | 04 Jun, 2018

UniQuest, The University of Queensland’s commercialization company, is leading Australia and competing globally in creating spin-out companies based on academic intellectual prop...Read more

FDA halts CRISPR and Vertex’s upcoming gene editing trial

BioTech |  News | 0 Comment | 01 Jun, 2018

Cambridge startup CRISPR Therapeutics and Boston-based Vertex Pharmaceuticals said that the FDA has put a hold on highly anticipated upcoming trial of their experimental gene editing drug f...Read more

Merck, Premier to codevelop new interventions for C. diff infection

BioTech |  News | 0 Comment | 31 May, 2018

Merck, known as MSD outside the United States and Canada, and Premier, a leading healthcare improvement company, have expanded their preventative and chronic disease care collaboration to i...Read more